SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,787.66 |
| Enterprise Value ($M) | 2,583.41 |
| Book Value ($M) | 356.34 |
| Book Value / Share | 6.07 |
| Price / Book | 7.82 |
| NCAV ($M) | 269.66 |
| NCAV / Share | 4.59 |
| Price / NCAV | 10.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.34 |
| Current Ratio | 5.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 368.81 |
| Assets | 455.49 |
| Liabilities | 99.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 43.95 |
| Operating Income | -156.55 |
| Net Income | -154.94 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -142.21 |
| Cash from Investing | -27.02 |
| Cash from Financing | 230.09 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Incyte Corp | 6.90 | 0.00 | |
| 13G/A | Federated Hermes, Inc. | 3.98 | -36.83 | |
| 13G/A | Biotechnology Value Fund L P | 4.80 | -7.59 | |
| 13G/A | Commodore Capital Lp | 8.20 | 73.73 | |
| 13G | Samlyn Capital, Llc | 5.90 | ||
| 13G/A | Flynn James E | 5.23 | 26.86 | |
| 13G/A | Wellington Management Group Llp | 3.48 | -45.55 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,155 | 263,175 | 11.08 | |
| 108,136 | 134,060 | 80.66 | |
| 73,276 | 168,103 | 43.59 | |
| 95,397 | 147,466 | 64.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNOV – MediciNova, Inc. | MORF – Morphic Holding, Inc. |
| MRNS – Marinus Pharmaceuticals, Inc. | MURA – Mural Oncology plc |
| NAII – Natural Alternatives International, Inc. |
Financial data and stock pages provided by
Fintel.io